All News

    FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors

    April 26th 2025, 6:00pm

    Article

    Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be presented at ASCO 2025.

    Crafting an Individual Treatment Plan for Patients With Prostate Cancer

    April 26th 2025, 2:00pm

    Video

    Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.

    Commitment to Patients Is Driven by a Lasting Promise

    April 25th 2025, 9:00pm

    Article

    Mikela Pettigrew, B.S.N., RN, OCN,, exemplifies extraordinary compassion and dedication. Every day, she fulfills a promise she made as a young caregiver.

    Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care

    April 25th 2025, 8:00pm

    Video

    Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemotherapy.

    New Options for ER+ Breast Cancer Spotlighted at Patient Event

    April 25th 2025, 7:00pm

    Article

    Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates.

    A Digital Detox for the Soul with Lynch Syndrome

    April 25th 2025, 5:00pm

    Article

    Unplugging from digital noise helped me find peace, clarity and room for growth during a season of emotional and mental renewal.

    Decipher Prostate Test Now Available for Metastatic Prostate Cancer

    April 25th 2025, 4:00pm

    Article

    Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

    Evorpacept With Keytruda Did Not Elicit Responses in Head and Neck Cancer

    April 25th 2025, 3:00pm

    Article

    In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 and ASPEN trials.

    ctDNA Clearance Linked to Improved Survival in Oncogene-Driven NSCLC

    April 25th 2025, 1:00pm

    Article

    Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.

    The Fearless Patient Advocate

    April 24th 2025, 9:00pm

    Article

    Kathleen Coughlin, although small in stature, is often referred to as the “Bulldozer.”